Vyleesi
NDC 0713-0897, bremelanotide, injection, from Cosette Pharmaceuticals, Inc..
- Product NDC
- 0713-0897
- Status
- Listed
- Labeler
- Cosette Pharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210557
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0713-0897 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BREMELANOTIDE ACETATE1.75 mg/.3mL
Pharmacologic classes
Melanocortin Receptor Agonist [EPC]; Melanocortin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0713-0897-04 | 00713089704 | 4 SYRINGE in 1 CARTON (0713-0897-04) / .3 mL in 1 SYRINGE (0713-0897-06) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf
Use it
Look up 0713-0897 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0713-0897 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0713-0897. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.